Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) posted a 25.7% year-on-year (YoY) decrease in net profit for the first nine months of fiscal year (FY) 2021/2022, according to the company’s financial income statement filed to the Egyptian Exchange (EGX) on May 22^nd.

Net profit stood at EGP 80.35 million in the nine-month period ended March 31^st, compared to a profit of EGP 108.17 million in the same period of FY 2020/2021.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.